Production of Sputnik V vaccine in Belarus to begin soon
MOSCOW. Feb 26 (Interfax) - Production of Russia's Sputnik V coronavirus vaccine will begin in Belarus in the near future, Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev said.
"Belarus was one of the first countries to complete the key stage of the technology transfer of production of the vaccine [Sputnik V], which will allow the vaccine's production to begin in Belarus in the near future," Dmitriev said at a conference on Sputnik V's production with representatives of the Belarusian Health Ministry on Friday.
"After part of domestic demand is covered, it will also be possible to export the vaccine from Belarus to other countries in order to help other states in fighting the pandemic," Dmitriev said.
Vaccination of Russian and Belarusian citizens is a priority, Dmitriev said.
Sergei Belyayev, director general of the Belarusian enterprise Belmedpreparaty, in turn, said that "at present, the first test batches of the Sputnik V vaccine, which should be tested for compliance with all standards, have been released."
Russia started a mass vaccination campaign against Covid-19 at the president's instruction on January 18. Russians are currently being inoculated chiefly using the Sputnik V vaccine developed by the Health Ministry's Gamaleya Research Center, which was the first coronavirus vaccine registered in the country.
According to the Health Ministry, about 4 million people have been vaccinated against Covid-19 in Russia.
As many as 38 countries have approved the Sputnik V vaccine to date.